|
136 |
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
Yusuf S, Bosch J.,Dagenais G, Zhu J, *Xavier D*, Liu L, *Pais P*, López-Jaramillo P, Leiter LA, et al., |
The New England Journal of Medicine |
2016 |
|
137 |
Global, regional, and national Incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015
|
Vos T, Allen C, Arora M, Cornaby L, Dandona L, *Xavier D*, et al.. |
Lancet |
2016 |
|
138 |
Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study
|
KK Sharma, R Gupta, *M Mathur*, V Natani, S Lodha, S Roy, *D Xavier*. |
Indian Heart Journal |
2016 |
|
139 |
Treatments and outcomes of cardiac arrhythmias after myocardial infarction: a prospective, follow up study in a tertiary-care hospital.
|
A Pandit, K Verghese, R Rathore, *D Xavier*. |
International Education and Research Journal |
2016 |
|
140 |
Cardiovascular risk factors and determinants of clinical outcomes in type 2 diabetic patients at a tertiary-care centre |
Maria Jose, Aparna Manjunath, Ganapathy Bantwal, *Denis Xavier* |
International Journal Basic Clin Pharmacol |
2016 |
|
141 |
Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America |
Carrillo-Larco RM, Miranda JJ, Li X, Cui C, Xu X, Ali M, Alam DS, Gaziano TA, Gupta R, Irazola V, Levitt NS, Prabhakaran D, Rubinstein A, Steyn K, Tandon N, Xavier D, Wu Y, Yan LL |
Glob Heart |
2016 |
|
142 |
Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial |
Xavier D, Gupta R, Kamath D, Sigamani A, Devereaux PJ, George N, Joshi R, Pogue J, Pais P, Yusuf S |
Lancet Diabetes Endocrinol |
2016 |
|
143 |
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. |
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, et al. |
Lancet |
2016 |
|
144 |
Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities: Results From the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases |
Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, Levitt NS, Miranda JJ, Ortiz AB, Steyn K, Wu Y, Xavier D, Yan LL, He J, Rubinstein A |
Glob Heart |
2016 |
|
145 |
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease |
Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, et al. |
N Engl J Med |
2016 |
|
146 |
Training and Capacity Building in LMIC for Research in Heart and Lung Diseases: The NHLBI-UnitedHealth Global Health Centers of Excellence Program |
Bloomfield GS, Xavier D, Belis D, Alam D, Davis P, Dorairaj P, Ghannem H, Gilman RH, Kamath D, et al. |
Glob Heart |
2016 |
|
147 |
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale |
Rao MP, Ciobanu AO, Lopes RD, Fox KA, Xian Y, Pokorney SD, Al-Khalidi HR, Jiang J, Kamath DY, Berwanger O, Xavier D, Bahit CM, Tajer C, Vinereanu D, Huo Y, Granger CB |
Am Heart J |
2016 |
|
148 |
Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations |
Gaziano TA, Abrahams-Gessel S, Alam S, Alam D, Ali M, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gutierrez L, Irazola V, Levitt NS, Miranda JJ, Bernabe-Ortiz A, Pandya A, Rubinstein A, Steyn K, Xavier D, Yan LL |
Glob Heart |
2016 |
|
149 |
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial |
Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FW |
BMJ |
2016 |
|
150 |
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease |
Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, et al. |
N Engl J Med |
2016 |